hydroxychloroquine
The week in review
Some key final reports were issued this week, and more COVID-19 news In COVID-19 news, the TGA said it is set to start publishing weekly reports on adverse events related …
RCTs show small or no effect on mortality, hospital admission
A WHO expert panel has strongly advised against use of hydroxychloroquine to prevent COVID-19, based on high-certainty evidence A World Health Organization (WHO) panel of experts, comprising intensive care physicians, …
The week in review
Pharmacy was in the media spotlight this week, with concerns aired about its role in COVID-19 testing and News Corp attacking it over medicines prices The Palaszczuk Government announced on …
Docs reiterate warning on hydroxychloroquine
The RACGP is once again urging Australians not to seek out or use hydroxychloroquine to “cure” or “prevent” the COVID-19 virus The warning from the Royal Australian College of General …
World news wrapup: 6 August 2020
Pharmacy slammed by dog attack victim; UK pharmacists face racism; remdesivir ring caught Snodland, England: A pharmacy in Kent has come under fire after a patient with a facial injury …
WHO drops two trial arms for COVID-19 treatment
The World Health Organization has discontinued the Solidarity Trial’s hydroxychloroquine and lopinavir/ritonavir arms as interim results show little or no benefit WHO has accepted the trial’s International Steering Committee recommendation …
Declining supply
Complaints about declining supply of medicine are on the rise, complicated by consumer behaviour thanks to COVID-19… what strategies can pharmacists use to manage the problem? PDL says that one …
More evidence against hydroxychloroquine
New data shows hydroxychloroquine does not help COVID-19 survival rates, as Australian doctors plead with employers not to require medical clearance US researchers have found more evidence that hydroxychloroquine – …
‘We can no longer vouch for the veracity of the primary data sources.’
Authors of a Lancet study on hydroxychloroquine treatment of COVID-19 have retracted their findings, as WHO announces it will resume its trial A study published in The Lancet has been …
Questions raised over research
A group of researchers, statisticians and clinicians, including doctors and pharmacists, have called for an independent audit and review of The Lancet’s large hydroxychloroquine study Last month, a large observational …
WHO hits ‘pause’ on trial
The international health organisation has temporarily suspended the hydroxychloroquine arm within its COVID-19 treatment trial in light of recent findings World Health Organization director-general Tedros Adhanom Ghebreyesus has confirmed the …
‘Urgent confirmation from randomised clinical trials is needed.’
A large observational study has linked hydroxychloroquine and chloroquine use to increased rates of mortality and heart arrhythmias in hospitalised COVID-19 patients A large observational study published in The Lancet has …